Rubella antibody status of patients attending a south-west London antenatal clinic, 2007-2012

British Journal of Biomedical Science

Volumn 71, Issue 3, 2014, Pages 111-114

  Mortlock, S ^a   Farthing, S ^b  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Pregnancy; Rubella; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; RUBELLA ANTIBODY; RUBELLA VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; ENZYME IMMUNOASSAY; ETHNIC DIFFERENCE; HUMAN; IMMUNITY; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; PRIORITY JOURNAL; RUBELLA; UNITED KINGDOM; VACCINATION; WORLD HEALTH ORGANIZATION; BLOOD; FEMALE; IMMUNOLOGY; PREGNANCY; RUBELLA VIRUS; VIROLOGY; YOUNG ADULT;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; LONDON; PREGNANCY; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; YOUNG ADULT;

EID: 84907956830     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2014.11669975     Document Type: Article

References (19)

1. World Health Organization. Rubella Fact Sheet. Geneva: WHO, 2013 (http://who.int/mediacentre/factsheets/fs367/en).
2. Lambert SR. Congenital rubella syndrome: the end is in sight. Br J Ophthalmol 2007; 91 (11): 1418-9.
3. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M et al. The seroepidemiology of rubella in Western Europe. Epidemiol Infect 2000; 125 (2): 347-57. Erratum in Epidemiol Infect 2001; 126 (2): 333.
4. Tookey P. Rubella in England, Scotland and Wales. Euro Surveill 2004; 9 (4): 21-3.
5. Derrough T, Bacci S, Lopalco PL. Letter to the editor: commitment needed for the prevention of congenital rubella syndrome in Europe. Euro Surveill 2012; 17 (10): pii: 20106.
6. Usonis V, Anca I, Andre F et al. Rubella revisited: where are we on the road to disease elimination in Central Europe? Vaccine 2011; 29 (49): 9141-7.
7. Seagrott V. MMR vaccine and Crohn's disease: ecological study of hospital admissions in England, 1991 to 2002. BMJ 2005; 330 (7500): 1120-1.
8. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001; 19 (27): 3632-5.
9. Owens SR. Injection of confidence. The recent controversy in the UK has led to falling MMR vaccination rates. EMBO J 2002; 3 (5): 406-9.
10. Fleck F. MMR controversy raises questions about publication ethics. Bull World Health Organ 2004; 82 (4): 311-2.
11. Lopalco P, Sprenger M. Do European doctors support measles, mumps, rubella vaccination programmes enough? Euro Surveill 2011; 16 (39): pii: 19979.
12. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996; 106 (2): 170-4.
13. Dimech W, Panagiotopoulos L, Francis B et al. Evaluation of eight anti-rubella virus immunoglobulin G immunoassays that report in international units per milliliter. J Clin Microbiol 2008; 46 (6): 1955-60.
14. Nardone A, Tischer A, Andrews N et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 2008; 86 (2): 118-25.
15. Alfredsson R, Sensson E, Trollfors B, Borres MP. Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Acta Paediatr 2004; 93 (9): 1232-7.
16. Matthews LA, Lawrance LM, Gray D, Gray S. An audit of rubella IgG antibody status in antenatal women in a NHS Trust over 5 years (2005-2009). Epidemiol Infect 2011; 139 (11): 1720-6.
17. Byrne L, Brant L, Reynolds C, Ramsey M. Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004-2009. Is rubella susceptibility increasing? Vaccine 2012; 30 (2): 161-7.
18. Tookey PA, Cortina-Borja M, Peckham CS. Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med 2002; 24 (3): 211-6.
19. Lawman S, Morton K, Best JM. Reasons for rubella susceptibility among pregnant women in West Lambeth. J R Soc Med 1994; 87 (5): 263-4.